EUTOS Long-Term Survival Score in Peruvian Chronic Myeloid Leukemia Patients Treated with Imatinib: A Real-World Experience

被引：0
|
作者：
Untama, Jose [1 ]
Pizarro, Marlies [1 ]
Huaman, Veronica [1 ]
Carbone, Ethan [1 ]
机构：
[1] Hosp Edgardo Rebagliati Essalud, Lima, Peru
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
CML; ELTS; SOKAL; chronic myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-729
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [21] EUTOS Score Is Predictive of Event-Free Survival, but Not for Progression-Free and Overall Survival in Patients with Early Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib: A Single Institution Experience
    Pagnano, Katia B.
    Lorand-Metze, Irene
    Miranda, Eliana C. M.
    Duarte, Vagner O.
    Delamain, Marcia T.
    Duarte, Gislaine O.
    De Souza, Carmino Antonio
    BLOOD, 2012, 120 (21)
  • [22] Prognostic Discrimination of Children and Adolescents with Chronic Myeloid Leukemia Based on the EUTOS Long Term Survival (ELTS) Score
    Millot, Frederic
    Guilhot, Joelle
    Suttorp, Meinolf
    Gunes, Adalet Meral
    Sedlacek, Petr
    De Bont, Evelina S.
    Li, Chi Kong
    Kalwak, Krzysztof
    Lausen, Birgitte
    Culic, Srdjana
    De Moerloose, Barbara
    Biondi, Andrea
    Baruchel, Andre
    BLOOD, 2016, 128 (22)
  • [23] SEX CORRELATED WITH DIFFERENCES IN LONG-TERM OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB
    Breccia, M.
    Colafigli, G.
    Molica, M.
    De Angelis, F.
    Quattrocchi, L.
    Latagliata, R.
    Mancini, M.
    Diverio, D.
    Alimena, G.
    HAEMATOLOGICA, 2015, 100 : 126 - 126
  • [24] LONG-TERM VALUE OF FLUCTUATION OF MOLECULAR RESPONSES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB
    Breccia, M.
    Colafigli, G.
    Molica, M.
    De Angelis, F.
    Quattrocchi, L.
    Latagliata, R.
    Mancini, M.
    Diverio, D.
    Alimena, G.
    HAEMATOLOGICA, 2015, 100 : 127 - 127
  • [25] MEANING OF MOLECULAR RESPONSES FLUCTUATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH LONG-TERM IMATINIB
    Breccia, M.
    Molica, M.
    Colafigli, G.
    Quattrocchi, L.
    Saracino, R.
    Latagliata, R.
    Mancini, M.
    Diverio, D.
    Alimena, G.
    HAEMATOLOGICA, 2016, 101 : 453 - 454
  • [26] LONG TERM MOLECULAR RESPONSE IN IMATINIB TREATED CHRONIC MYELOID LEUKEMIA PATIENTS
    Jovanovic, V.
    Bogdanovic, D.
    Djordjevic, A.
    Dencic-Fekete, S.
    Gotic, D.
    HAEMATOLOGICA, 2012, 97 : 542 - 542
  • [27] Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents
    Millot, Frederic
    Guilhot, Joelle
    Suttorp, Meinolf
    Gunes, Adalet Meral
    Sedlacek, Petr
    De Bont, Eveline
    Li, Chi Kong
    Kalwak, Krzysztof
    Lausen, Birgitte
    Culic, Srdjana
    Dworzak, Michael
    Kaiserova, Emilia
    De Moerloose, Barbara
    Roula, Farah
    Biondi, Andrea
    Baruchel, Andre
    HAEMATOLOGICA, 2017, 102 (10) : 1704 - 1708
  • [28] Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy Analysis
    Osorio, Maria Jose Mela
    Moiraghi, Beatriz
    Osycka, Maria Victoria
    Pavlovsky, Miguel A.
    Varela, Ana Ines
    Del Prete, Georgina Emilia Bendek
    Tosin, Maria Fernanda
    Perez, Mariel Ana
    Riva, Maria Elisa
    Berrios, Roxana Ramirez
    Fernandez, Isolda
    Massa, Federico Sackmann
    Giere, Isabel
    Sighel, Carolina
    Pavlovsky, Carolina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (03): : 158 - 164
  • [29] EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience
    Jabbour, Elias
    Cortes, Jorge
    Nazha, Aziz
    O'Brien, Susan
    Quintas-Cardama, Alfonso
    Pierce, Sherry
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    BLOOD, 2012, 119 (19) : 4524 - 4526
  • [30] Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results
    Palandri, Francesca
    Testoni, Nicoletta
    Luatti, Simona
    Marzocchi, Giulia
    Baldazzi, Carmen
    Stacchini, Monica
    Castagnetti, Fausto
    Breccia, Massimo
    Specchia, Giorgina
    Pane, Fabrizio
    Saglio, Giuseppe
    Martinelli, Giovanni
    Baccarani, Michele
    Rosti, Gianantonio
    LEUKEMIA & LYMPHOMA, 2009, 50 (01) : 114 - 118
12345